ArticleJournal of thoracic disease2026

First-line third-generation EGFR-TKIs for advanced EGFR-mutated non-small cell lung cancer: a systematic review and network meta-analysis of randomized controlled trials.

Xiaomin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.